These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 12029991)
1. [Revision of Japanese guideline for prevention of CHD based on recent evidences]. Teramoto T Nihon Rinsho; 2002 May; 60(5):899-907. PubMed ID: 12029991 [TBL] [Abstract][Full Text] [Related]
2. [Guideline for diagnosis and management of hyperlipidemia for prevention of atherosclerosis in Japan]. Teramoto T Nihon Rinsho; 1999 Dec; 57(12):2651-6. PubMed ID: 10638191 [TBL] [Abstract][Full Text] [Related]
3. [New guideline for the management of hyperlipidemia according to patient category and global risk chart]. Mabuchi H Nihon Rinsho; 2002 May; 60(5):908-15. PubMed ID: 12029992 [TBL] [Abstract][Full Text] [Related]
4. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
5. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related]
6. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort. Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952 [TBL] [Abstract][Full Text] [Related]
7. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
8. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002. Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658 [TBL] [Abstract][Full Text] [Related]
9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178 [TBL] [Abstract][Full Text] [Related]
10. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia. Sorensen SV; Frick KD; Wade A; Simko R; Burge R Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159 [TBL] [Abstract][Full Text] [Related]
11. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study). Garmendia F; Brown AS; Reiber I; Adams PC Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012 [TBL] [Abstract][Full Text] [Related]
12. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Bersot TP; Pépin GM; Mahley RW Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998 [TBL] [Abstract][Full Text] [Related]
13. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III. Talbert RL Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701 [TBL] [Abstract][Full Text] [Related]
14. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
15. Adult Treatment Panel III: do we really need another set of cholesterol guidelines? Clearfield MB J Am Osteopath Assoc; 2002 May; 102(5 Suppl 1):S6-11. PubMed ID: 12046681 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol: precursor to many lipid disorders. Jones PH Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815 [TBL] [Abstract][Full Text] [Related]
17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE; Feely J; Sigurdsson EL; Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [TBL] [Abstract][Full Text] [Related]
18. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry. Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876 [TBL] [Abstract][Full Text] [Related]
19. Risk evaluation of coronary heart disease and cerebrovascular disease by the Japan Atherosclerosis Society Guidelines 2002 using the cohort of the Holicos-PAT study. Koizumi J; Shimizu M; Miyamoto S; Takeda R; Ohka T; Kanaya H; Uno Y; Ueda K; Takegoshi T; Wakasugi T; Ohta M; Sumitani T; Kametani T; Watanabe A; Fujita H; Hifumi S; Origasa H; Mabuchi H J Atheroscler Thromb; 2005; 12(1):48-52. PubMed ID: 15725696 [TBL] [Abstract][Full Text] [Related]
20. [Achievement of the therapeutic goals for dyslipidemia in clinical practice: results of a survey among general practice physicians from Lombardy]. Tragni E; Catapano AL; Bertelli A; Poli A Ital Heart J; 2003 Dec; 4 Suppl 7():47S-57S. PubMed ID: 14983746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]